1.1 	A bill for an act
1.2 	relating to human services; directing the commissioner to provide an annual report 
1.3 	on treatments for sickle cell disease;amending Minnesota Statutes 2022, section 
1.4 	256.01, by adding a subdivision.
1.5 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.6 	Section 1. Minnesota Statutes 2022, section 256.01, is amended by adding a subdivision 
1.7 	to read:
1.8 		Subd. 44.Treatment of sickle cell disease. (a) The commissioner of human services 
1.9 	shall conduct an annual review of all medications and forms of treatment for sickle cell 
1.10 	disease and services for medical assistance enrollees with a diagnosis of sickle cell disease 
1.11 	that are eligible for coverage under the medical assistance program. The purpose of the 
1.12 	annual review is to determine if the available covered medications, treatments, and services 
1.13 	are adequate to meet the needs of enrollees with a diagnosis of sickle cell disease and whether 
1.14 	the commissioner should seek to add additional medications, treatments, or services.
1.15 	(b) When conducting the annual review required by this subdivision, the commissioner 
1.16 	shall solicit and consider input from the general public, with specific emphasis on attempting 
1.17 	to receive input from persons or groups with knowledge and experience in the area of sickle 
1.18 	cell disease treatment.
1.19 	(c) On or before January 15, 2025, and on or before January 15 each year thereafter, the 
1.20 	commissioner shall submit a report to the chairs and ranking minority members of the 
1.21 	legislative committees with jurisdiction over medical assistance policy and finance that 
1.22 	details the commissioner's findings from the annual review required by this subdivision, as 
1.23 	well as any recommendations to the legislature based upon those findings. The commissioner 
2.1 	shall publish the annual report required by this subdivision to the Department of Human 
2.2 	Services website in a manner accessible by the general public.
2.3 	(d) Notwithstanding subdivision 42, the reporting requirement under this subdivision 
2.4 	does not expire.